News
Artificial intelligence, technology, science, health and education — reported daily, with the original source attached to every item.
Showing articles about phase 1 trial
2 stories
Two Independent Trials Report Responses in KRAS G12D Cancers, but Nature Medicine Editorial Urges Caution
Two Nature Medicine trials of oral and intravenous KRAS G12D inhibitors report response rates of 41% and 63.3% in advanced solid tumors and…
Phase 1 Trial Finds a Cancer-Style T-Cell Engager Can Push Refractory Lupus Into Remission
A phase 1 trial of A-319, a CD3×CD19 bispecific antibody adapted from cancer therapy, pushed most of 12 treatment-resistant lupus patients …